Hospital at the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Location status: Recruiting
Location contact
Everett Seay
CONTACT
Julianna Rodin, MD
PRINCIPAL_INVESTIGATOR
Rafa Khan
CONTACT
NCT Number: NCT06789770
This project will provide important new information regarding (1) the relationship between route of breathing and airway collapsibility and (2) whether route of breathing during DISE (Drug-Induced Sleep Endoscopy) is representative of natural sleep.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Philadelphia, Pennsylvania, 19104, United States
Location status: Recruiting
Everett Seay
CONTACT
Julianna Rodin, MD
PRINCIPAL_INVESTIGATOR
Rafa Khan
CONTACT
As part of standard of care, a drug-induced sleep endoscopy will be done, where route of breathing will be determined as a percentage of total breaths (during baseline, lateral sleep and maneuver). As part of the research procedure, an in-laboratory Polysomnogram will be conducted as study procedure including a oronasal pressure signal cannula to assess route of breathing.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Within 3 months of enrollment
Participants will be classified as oral breathers if more than 50% of their total breaths during DISE occur through the oral route; otherwise, they will be classified as nasal breathers. The pattern of upper airway collapse will be characterized using the VOTE classification system, a standardized DISE scoring tool assessing the Velum (V), Oropharynx (O), Tongue Base (T), and Epiglottis (E). Each anatomical site is graded on a 0-2 scale, where 0 = no obstruction, 1 = partial obstruction, and 2 = complete obstruction. This outcome assesses relationships between breathing route classification and the anatomical pattern and severity of upper airway collapse
Time frame: Within 3 months of enrollment
For each participant, every breath within the analysis window will be classified as oral, nasal, or mixed-approximately 5 minutes of stable breathing during DISE and ≥4 hours during overnight polysomnography (PSG). The primary output will be the percentage of breaths in each category for both modalities. Agreement between DISE-based and PSG-based breathing-route classification will be evaluated using statistical agreement methods (e.g., Bland-Altman analyses, concordance metrics).
Contact information is provided by the study sponsor or research team.
University of Pennsylvania
Other
The Impact of Nasal Versus Oral Breathing on Measures of Drug-Induced Sleep Endoscopy
Acronym: Nasal vs Oral
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07369011
Apnea, Body Weight
Cullman, Alabama, United States
View Trial DetailsNCT00695214
Apnea, Dyssomnias
Santa Monica, California, United States
View Trial DetailsNCT03860233
Apnea, Dyssomnias
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05382754
Apnea, Dyssomnias
Philadelphia, Pennsylvania, United States
View Trial Details